CGEM: cullinanoncology.com Net earnings per share for the last 12 months

Symbol and logo of brand Cullinan Therapeutics, Inc. (CGEM)

High R&D expenditures in oncology create powerful leverage for future superprofits for Cullinan Therapeutics (CGEM). Net earnings per share over 12 months visualize this trend, where the value of -3.30 characterizes this level. This strengthens the company's status as an immuno-oncology elite and confirms the successful expansion of the brand into the autoimmune pathology sector.

CGEM (Cullinan Therapeutics) Net earnings per share (EPS TTM) history from 07/04/2022 to 11/17/2026

Analytical breakdowns for Cullinan Therapeutics

Basic company analysis:Cullinan Therapeutics - CGEM
Manufactured products of Cullinan Oncology

The specifics of R&D in oncology therapy at Cullinan Therapeutics (CGEM), characterized by high clinical trial risks, make monitoring real returns critically important. The current level of rolling earnings per share aggregates net income for the year, neutralizing quarterly fluctuations and one-time write-offs, which allows investors to assess the fundamental stability of this high-risk asset through the lens of actual earnings per share.

Who Cullinan Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) enliventherapeutics.com|Earnings per share for the last twelve months ORIC Pharmaceuticals, Inc. (ORIC)|RLAY (Relay Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) NRIX (Nurix Therapeutics Inc)|Net earnings per share for the trailing year Tyra Bio|Verastem Oncology - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Monte Rosa Therapeutics, Inc.|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)